<p>Andreas Matouschek and Keith Tyo of Northwestern University in the U.S. will develop synthetic compounds that target essential proteins in the Plasmodium parasite for destruction by its own protein degradation mechanisms. This strategy could aid new small molecule drug development efforts to combat malaria.</p>


Andreas Matouschek and Keith Tyo of Northwestern University in the U.S. will develop synthetic compounds that target essential proteins in the Plasmodium parasite for destruction by its own protein degradation mechanisms. This strategy could aid new small molecule drug development efforts to combat malaria.